title: Clinical characteristics of patients in a case control study of sarcoidosis.
abstract: Sarcoidosis may be affected by sex, race, and age. A Case Control Etiologic Study of Sarcoidosis (ACCESS) enrolled 736 patients with sarcoidosis within 6 mo of diagnosis from 10 clinical centers in the United States. Using the ACCESS sarcoidosis assessment system, we determined organ involvement for the whole group and for subgroups differentiated by sex, race, and age (less than 40 yr or 40 yr and older). The study population was heterogeneous in terms of race (53% white, 44% black), sex (64% female, 36% male), and age (46% < 40 yr old, 54% > or = 40 yr old). Women were more likely to have eye and neurologic involvement (chi(2) = 4.74, p < 0.05 and chi(2) = 4.60, p < 0.05 respectively), have erythema nodosum (chi(2) = 7.28, p < 0.01), and to be age 40 yr or over (chi(2) = 6.07, p < 0.02) whereas men were more likely to be hypercalcemic (chi(2) = 7.38, p < 0.01). Black subjects were more likely to have skin involvement other than erythema nodosum (chi(2) = 5.47, p < 0.05), and eye (chi(2) = 13.8, p < 0.0001), liver (chi(2) = 23.3, p < 0.0001), bone marrow (chi(2) = 18.8, p < 0.001), and extrathoracic lymph node involvement (chi(2) = 7.21, p < 0.01). We conclude that the initial presentation of sarcoidosis is related to sex, race, and age.
authors.affiliation: University of Cincinnati Medical Center, Cincinnati, Ohio 45267-0565, USA. Bob.Baughman@uc.edu
authors.forename: R P
authors.initials: RP
authors.lastname: Baughman
authors.forename: A S
authors.initials: AS
authors.lastname: Teirstein
authors.forename: M A
authors.initials: MA
authors.lastname: Judson
authors.forename: M D
authors.initials: MD
authors.lastname: Rossman
authors.forename: H
authors.initials: H
authors.lastname: Yeager
authors.forename: E A
authors.initials: EA
authors.lastname: Bresnitz
authors.forename: L
authors.initials: L
authors.lastname: DePalo
authors.forename: G
authors.initials: G
authors.lastname: Hunninghake
authors.forename: M C
authors.initials: MC
authors.lastname: Iannuzzi
authors.forename: C J
authors.initials: CJ
authors.lastname: Johns
authors.forename: G
authors.initials: G
authors.lastname: McLennan
authors.forename: D R
authors.initials: DR
authors.lastname: Moller
authors.forename: L S
authors.initials: LS
authors.lastname: Newman
authors.forename: D L
authors.initials: DL
authors.lastname: Rabin
authors.forename: C
authors.initials: C
authors.lastname: Rose
authors.forename: B
authors.initials: B
authors.lastname: Rybicki
authors.forename: S E
authors.initials: SE
authors.lastname: Weinberger
authors.forename: M L
authors.initials: ML
authors.lastname: Terrin
authors.forename: G L
authors.initials: GL
authors.lastname: Knatterud
authors.forename: R
authors.initials: R
authors.lastname: Cherniak
mesh_terms: D000328:Adult; D017677:Age Distribution; D000367:Age Factors; D000368:Aged; D044383:Black People; D016022:Case-Control Studies; D004417:Dyspnea / Q000209:etiology; D004893:Erythema Nodosum / Q000209:etiology; D005260:Female; D005541:Forced Expiratory Volume; D006801:Humans; D006934:Hypercalcemia / Q000209:etiology; D016014:Linear Models; D008297:Male; D008875:Middle Aged; D016016:Proportional Hazards Models; D012507:Sarcoidosis / Q000145:classification / Q000150:complications / Q000453:epidemiology* / Q000473:pathology*; D012720:Severity of Illness Index; D012727:Sex Characteristics; D017678:Sex Distribution; D014481:United States / Q000453:epidemiology; D014797:Vital Capacity; D044465:White People; D001741:Black or African American